NIH Hands Exclusive License for Vision-Restoring PEDF Peptides
Published Date: 4/1/2026
Notice
Summary
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides that could help treat eye diseases causing vision loss. This means the company will have the sole right to develop and sell this new treatment, potentially speeding up cures for retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09808 — Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment
The National Cancer Institute is offering a cool new cancer treatment invention called hetIL-15 that works better when combined with other drugs like Fenofibrate and quizartinib. This combo could help patients by making immune cells stronger and safer, potentially beating tough cancers like breast and pancreatic tumors. Researchers and companies interested in developing or licensing this tech should act soon to join the fight against cancer and bring these treatments to life.
2026-09292 — Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The government has a cool new discovery that makes certain immune cells, called T cells, better at fighting cancer by turning off some ‘brakes’ inside them. This could lead to stronger treatments for cancer, infections, and autoimmune diseases. Companies interested in developing this technology can license it now, potentially speeding up new, powerful therapies and boosting health outcomes.
2026-08606 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings protect sensitive info like trade secrets and personal data, so they’re not open to the public. Researchers applying for grants should note these dates as they impact funding decisions and the review process timeline.
2026-08638 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications. These meetings affect researchers seeking funding for brain, behavior, and imaging studies, keeping sensitive info private. No new costs or deadlines are announced, but these reviews shape which projects get money next.
2026-08456 — Proposed Collection; 60-Day Comment Request; NIH Office of Intramural Training & Education-Application, Registration, and Alumni Systems Office of the Director
The NIH Office of Intramural Training & Education wants your thoughts on updating their application, registration, and alumni systems. This affects students, trainees, and alumni who use these systems, aiming to make things smoother and less time-consuming. You’ve got 60 days to share your ideas before they finalize the changes—no extra costs involved, just better tech and less hassle!
2026-08461 — Submission for OMB Review; 30-Day Comment Request Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research (Office of the Director)
The NIH is asking for public feedback on a survey about how clinical research training helps healthcare pros in schools and labs. This is a quick 30-day chance to share your thoughts before June 1, 2026. No big costs or changes yet—just making sure the survey is clear and useful for everyone involved.
Previous / Next Documents
Previous: 2026-06282 — Brightwood Capital SBIC IV, LP; Notice Seeking Exemption Under Section 312 of the Small Business Investment Act, Conflicts of Interest
Brightwood Capital SBIC IV, LP wants to lend money to The Smith and Oby Holding Company to help it grow. Because some related Brightwood funds already own a big chunk of Smith and Oby, this deal is a conflict of interest and needs special approval. People have 15 days from April 1, 2026, to share their thoughts before the SBA decides.
Next: 2026-06284 — Statement of Organization, Functions, and Delegations of Authority; Office of The National Coordinator for Health Information Technology
The Department of Health and Human Services is shaking things up by removing the Assistant Secretary for Technology Policy role and making the Office of the National Coordinator for Health Information Technology (ONC) a standalone office again. ONC will focus on leading health IT efforts without the extra tech roles like Chief AI or Data Officers. These changes take effect immediately and aim to streamline how health information tech supports Americans’ health.